http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017354674-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fc4f20b8d6ccd724a3305db2cb051c2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 |
| filingDate | 2016-06-14^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cb454ccc6fcecfc8d8a2be337c7758b |
| publicationDate | 2017-12-14^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2017354674-A1 |
| titleOfInvention | Administration of synergistic amounts of modified citrus pectin and honokiol to treat inflammation and anti-oxidant needs |
| abstract | A method of inhibiting or reducing inflammation in a mammal comprises administering MCP or similar Gal-3 binding moiety with honokiol in a range of about 8-10:1, by weight, MCP to honokiol. By pursuing complimentary pathways, a synergistic combination is achieved, where the reduction or degree of inflammation inhibition is greater than would be expected by the added administration of these two agents. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3814372-A4 |
| priorityDate | 2016-06-14^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 361 of 361.